Pinnacle Wealth Planning Services’s 10x Genomics TXG Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$175K	Sell	1,933 -2,078	-52%	-$122K	0.02%	559
2026 Q2	$154K	Sell	4,011 -45	-1%	-$1.18K	0.01%	648
2026 Q1	$86.1K	Buy	4,056 +114	+3%	+$2.28K	0.01%	875
2025 Q4	$64.3K	Buy	+3,942	New	+$59.5K	0.01%	1034
2021 Q1	–	Sell	-13	Closed	-$2K	–	1829
2020 Q4	$2K	Buy	+13	New	+$1.89K	﹤0.01%	1992

Other funds holding TXG

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Convergence Investment Partners Palm Beach Gardens, Florida $1.35B AUM 71.9% 1-Year Est. Return

Cookson Peirce & Co Pittsburgh, Pennsylvania $2.77B AUM 64.09% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Financial Consulate Hunt Valley, Maryland $899M AUM 14.82% 1-Year Est. Return

MIC

Maxi Investments CY Limassol, Cyprus $545M AUM 21.2% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return

Pinnacle Wealth Planning Services's TXG Position: Q3 2026 in Review

Pinnacle Wealth Planning Services reduced its 10x Genomics (TXG) stake by 52% in Q3 2026, selling an estimated $122K and leaving 1,933 shares worth $175K. The position accounts for 0.02% of the portfolio, ranked #559.

Pinnacle Wealth Planning Services first reported a position in TXG in Q4 2020 and has held it in 5 quarters since. 126 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

Pinnacle Wealth Planning Services held 1,933 shares of 10x Genomics worth $175K as of Q3 2026.
Pinnacle Wealth Planning Services sold 2,078 10x Genomics shares in Q3 2026, an estimated $122K.
10x Genomics made up 0.02% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #559 holding.
Pinnacle Wealth Planning Services first reported a position in 10x Genomics in Q4 2020 and has held it in 5 quarters since.
126 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.